Lisdexamfetamine dimesylateProduct ingredient for Lisdexamfetamine

Name
Lisdexamfetamine dimesylate
Drug Entry
Lisdexamfetamine

Lisdexamfetamine is a prodrug of dextroamphetamine, a central nervous system stimulant known as d-amphetamine,3 covalently attached to the naturally occurring amino acid L-lysine.1 Lisdexamfetamine is the first chemically formulated prodrug stimulant 3 and was first approved by the FDA in April 2008.1 It was also approved by Health Canada in February 2009.7 Lisdexamfetamine works to treat attention deficit hyperactivity disorder and binge eating disorder 1 by blocking dopamine and norepinephrine reuptake and increasing their levels in the extraneuronal space.6

Accession Number
DBSALT002824
Structure
Synonyms
Lis-dexamfetamine dimesylate / Lisdexamfetamine mesilate
External IDs
NRP 104 / NRP-104 / NRP104 / SPD 489 / SPD489